ClinicalTrials.Veeva

Menu

Perfusion Index Changes in Cardiovascular Autonom Neuropathia Type-2 Dm Whit Spinal Anesthesia (PI)

E

Erzincan University

Status

Unknown

Conditions

Anesthesia; Adverse Effect

Treatments

Device: perfusion index monitor
Diagnostic Test: ewing test

Study type

Observational

Funder types

Other

Identifiers

NCT03869775
ErzincanU

Details and patient eligibility

About

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Full description

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Enrollment

240 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • the patient will be operated with spinal anesthesia
  • over 18 years
  • no additional disease and only DM

Exclusion criteria

  • patients with additional disease
  • patients under 18 years of age
  • patients contraindicated in spinal anesthesia

Trial design

240 participants in 3 patient groups

control group
Description:
no additional disease
Treatment:
Device: perfusion index monitor
working group-1
Description:
additional disease only DM and no cardıovascular autonomous neuropathıa
Treatment:
Diagnostic Test: ewing test
Device: perfusion index monitor
working group-2
Description:
additional disease only DM and pozitif cardıovascular autonomous neuropathıa
Treatment:
Diagnostic Test: ewing test
Device: perfusion index monitor

Trial contacts and locations

1

Loading...

Central trial contact

FARUK SUBAŞI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems